European Review for Medical and Pharmacological Sciences

European Review for Medical
and Pharmacological Sciences

European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research.

The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine.

We encourage scientists from all around the world to submit their research regarding PACS (Post-Acute COVID-19 Syndrome).
Any contribution is important for the Scientific Community.

The full text of the articles can be downloaded free of charge.

Indexed in PubMed

CiteScore: 6.3

Issues Archive - Page 327

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2950-2959
DOI: 10.26355/eurrev_201904_17575

The association between clinical and laboratory parameters in thyroid disease and nonthyroidal illness in young women

B. Lisowska-Myjak, A. Puchalska, N. Hałasa, M. Płazińska, A. Strawa
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2944-2949
DOI: 10.26355/eurrev_201904_17574

Correlation analysis of TLR9 and IL-23 expression in patients with lupus nephritis

Z.-F. Jiao, Y.-M. Zhang, X.-F. Ma, X. Li, Y. Li, Y.-J. Mao
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2935-2943
DOI: 10.26355/eurrev_201904_17573

Influences of hucMSC-exosomes on VEGF and BMP-2 expression in SNFH rats

R. Li, C. Chen, R.-Q. Zheng, L. Zou, G.-L. Hao, G.-C. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2924-2934
DOI: 10.26355/eurrev_201904_17572

A pilot study of human mesenchymal stem cells from visceral and sub-cutaneous fat tissue and their differentiation to osteogenic phenotype

F. Mastrangelo, S. Scacco, A. Ballini, R. Quaresima, A. Gnoni, D. De vito, A. Scarano, G. Dipalma, C. Gargiulo Isacco, S. Cantore, M.F. Coscia, F. Pettini, G. Sammartino, M. Cicciù, P. Conti, L. Lo Muzio
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2916-2923
DOI: 10.26355/eurrev_201904_17570

Stemness genes expression in naïve vs. osteodifferentiated human dental-derived stem cells

A. Ballini, A. Di Benedetto, D. De Vito, A. Scarano, S. Scacco, L. Perillo, F. Posa, G. Dipalma, F. Paduano, M. Contaldo, M. Grano, G. Brunetti, G. Colaianni, M. Di Cosola, S. Cantore, G. Mori
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2908-2915
DOI: 10.26355/eurrev_201904_17569

LncRNA HOTTIP promotes proliferation and cell cycle progression of acute myeloid leukemia cells

M.-F. Zhuang, L.-J. Li, J.-B. Ma
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2898-2907
DOI: 10.26355/eurrev_201904_17568

HOXD-AS1: a novel oncogenic long intergenic non-coding RNA in humans

S.C. Xie, Y.J. Yang, J.Q. Zhang, S. Zhou, S.W. Xie, Y.Y. Hua
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2888-2897
DOI: 10.26355/eurrev_201904_17567

Long noncoding RNA DSCAM-AS1 is associated with poor clinical prognosis and contributes to melanoma development by sponging miR-136

Y.-L. Huang, Q. Xu, X. Wang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2880-2887
DOI: 10.26355/eurrev_201904_17566

LncRNA PVT1 knockdown affects proliferation and apoptosis of uveal melanoma cells by inhibiting EZH2

X.-M. Huang, S.-S. Shi, T.-M. Jian, D.-R. Tang, T. Wu, F.-Y. Sun
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2870-2879
DOI: 10.26355/eurrev_201904_17565

Overexpression of miR-770 indicates a favorable prognosis and suppresses tumorigenesis by modulating PI3K-AKT pathway in glioma

F.-Q. Feng, G.-S. Liu, J.-C. Li, L.-Z. Chen
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2863-2869
DOI: 10.26355/eurrev_201904_17564

MiRNA-485-5p, inhibits esophageal cancer cells proliferation and invasion by down-regulating O-linked N-acetylglucosamine transferase

D.-L. Han, L.-L. Wang, G.-F. Zhang, W.-F. Yang, J. Chai, H.-M. Lin, Z. Fu, J.-M. Yu
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (7): 2803-2808
DOI: 10.26355/eurrev_201904_17555

European Review for Medical
and Pharmacological Sciences

Issues Archive - Page 327

The association between clinical and laboratory parameters in thyroid disease and nonthyroidal illness in young women

Correlation analysis of TLR9 and IL-23 expression in patients with lupus nephritis

Influences of hucMSC-exosomes on VEGF and BMP-2 expression in SNFH rats

A pilot study of human mesenchymal stem cells from visceral and sub-cutaneous fat tissue and their differentiation to osteogenic phenotype

Stemness genes expression in naïve vs. osteodifferentiated human dental-derived stem cells

LncRNA HOTTIP promotes proliferation and cell cycle progression of acute myeloid leukemia cells

HOXD-AS1: a novel oncogenic long intergenic non-coding RNA in humans

Long noncoding RNA DSCAM-AS1 is associated with poor clinical prognosis and contributes to melanoma development by sponging miR-136

LncRNA PVT1 knockdown affects proliferation and apoptosis of uveal melanoma cells by inhibiting EZH2

Overexpression of miR-770 indicates a favorable prognosis and suppresses tumorigenesis by modulating PI3K-AKT pathway in glioma

Survival benefit for patients treated in a certified head and neck tumor center

MiR-506 suppresses papillary thyroid carcinoma cell proliferation and metastasis via targeting IL17RD

MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2

LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15

MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF

CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p

MiRNA-485-5p, inhibits esophageal cancer cells proliferation and invasion by down-regulating O-linked N-acetylglucosamine transferase

Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients

LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer

HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway